Aline Renneville

10PUBLICATIONS
74CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Nanotoxicology, health and safetyMolecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 31, 2025
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid Disorders.

David Fandrei, Jean Pegliasco, Florence Pasquier

|Nov 23, 2024
Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Donia Hidaoui, Audrey Porquet, Rabie Chelbi

|Oct 14, 2024
Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO's pharmacovigilance database.

Pierre-Marie Morice, Sabine Khalife-Hachem, Marion Sassier

|Apr 24, 2024
RAS mutations in myeloid malignancies: revisiting old questions with novel insights and therapeutic perspectives.

Dana Alawieh, Leila Cysique-Foinlan, Christophe Willekens

|Nov 09, 2023
Clonal Hematopoiesis in Patients With Cancer: How Much Should We Care?

Aline Renneville, Elsa Bernard, Jean-Baptiste Micol

|Aug 21, 2023
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.

Christophe Willekens, Claude Chahine, Matteo Dragani

Pageof 2

Frequent Collaborators

4 joint publications

Jean-Baptiste Micol

3 joint publications

Elsa Bernard

3 joint publications

Raphael Itzykson

2 joint publications

Christophe Marzac